{
    "2021-02-24": [
        [
            {
                "time": "2023-10-01",
                "original_text": "AbbVie's SKYRIZIÂ® for the Treatment of Moderate to Severe Plaque Psoriasis now Publicly Reimbursed across Canada",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "SKYRIZI",
                        "Reimbursed",
                        "Canada",
                        "Plaque Psoriasis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Top 15 Pharmaceutical Companies With Highest R&D Spending",
                "features": {
                    "keywords": [
                        "Pharmaceutical",
                        "R&D",
                        "Spending"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}